A Web producer, Kopp most recently worked as a freelance reporter. She has previously worked at Politico and AIS Health. Before that, she interned with the Center for Responsive Politics.
The short, technical paragraph calls for the Internal Revenue Service to allow patients with high-deductible health plans to receive care for chronic diseases, including drugs, before meeting their deductibles.
To solve the crisis of high drug prices, the group discussed strengthening the monopoly rights of pharmaceuticals overseas, ending discounts for low-income hospitals and accelerating drug approvals by the Food and Drug Administration.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Although drug price legislation has stalled in some states, some advocates say there's plenty of grass-roots support for this legislation on insulin prices but that advocacy organizations are not listening to the right people.
The U.S. drug industry has strongly opposed efforts to open the borders to drug imports, but pharma lobbying group PhRMA is not mentioned in the Partnership for Safer Medicines' advertising blitz.
Patients want cheaper medicine; the pharmaceutical industry wants to maximize revenue.